Glulisine Pre- and Postmeal

Sanofi

Status and phase: Completed; Phase 1

Conditions: Diabetes Mellitus Type 1

Treatments: Drug: Insulin glulisine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00290043

HMR1964

HMR1964A/1008

Details and patient eligibility

About

To investigate in type 1 diabetic patients the glucodynamic response to HMR1964 insulin and RHI (HOE31HPR100) injected subcutaneously before and after a standard meal

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Type 1 diabetes mellitus

Exclusion Criteria:

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)